![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Large/26d9502b-3adb-45b2-8e3e-09c6bde9c684.jpg)
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Small/26d9502b-3adb-45b2-8e3e-09c6bde9c684.jpg)
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Small/80604860-7a07-42a8-ad80-e07140d47ab9.jpg)
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Small/cdbd01dd-0626-4302-8478-76255654f986.jpg)
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Small/0dc824ef-04d4-4693-9d52-7a4125dcde9a.jpg)
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](/ProductImageEN/2024-05/Small/f54919e7-5e33-4b6c-83eb-351a983aaf78.jpg)
Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]- NEW
| Price | $85 | $80 | $75 |
| Package | 1box | 5box | 10box |
| Min. Order: | 1box |
| Supply Ability: | 2000box |
| Update Time: | 2024-09-12 |
Product Details
| Product Name: Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]- | CAS No.: 2413974-52-2 |
| EC-No.: 974-152-2 | Min. Order: 1box |
| Purity: 99+ | Supply Ability: 2000box |
| Release date: 2024/09/12 |
| Common Name | MT-802 | ||
|---|---|---|---|
| CAS Number | 2231744-29-7 | Molecular Weight | 787.82 |
| Density | N/A | Boiling Point | N/A |
| Molecular Formula | C41H41N9O8 | Melting Point | N/A |
| MSDS | N/A | Flash Point | N/A |
| Description | MT-802 is a potent BTK degrader based on PROTAC technology, with a DC50 of 1 nM. MT-802 has potential to treat C481S mutant chronic lymphocytic leukemia (CLL)[1]. |
|---|---|
| Related Catalog | Research Areas >> Cancer Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk Signaling Pathways >> PROTAC >> PROTAC |
| Target | DC50: 1 nM (BTK)[1]. |
| In Vitro | MT-802 degrades BTK with a DC50 of 9.1 nM with maximal degradation being observed by 250 nM[1]. |
| References | [1]. Buhimschi AD, et al. Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation. Biochemistry. 2018 Jul 3;57(26):3564-3575. |
| Molecular Formula | C41H41N9O8 |
|---|---|
| Molecular Weight | 787.82 |
  Storage condition | -20°C |
Company Profile Introduction
You may like
-
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](https://img.chemicalbook.com/ProductImageEN/2024-05/Large/1d8124b2-1b05-4251-9df1-98270c053bb8.jpg)
CAS:2413974-52-2
$5.00 / 1kg
-
![Thiourea, N-(4-methoxyphenyl)-N'-[5-(5-nitro-2-furanyl)-1,3,4-thiadiazol-2-yl]-](https://img.chemicalbook.com/ProductImageEN/2024-05/Large/3053c0fb-2403-4d39-8eae-2ea66c10b2ed.jpg)
CAS:2413974-52-2
$6.00 / 1kg
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1g |
VIP1Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-04-01 | |
| $20.00/1kg |
VIP1Y
|
Shaanxi Franta Biotechnology Co., Ltd
|
2024-03-29 | |
| $50.00/1g |
VIP2Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2024-07-09 |
China- Since: 2024-04-30
- Address: Room 815, Block A, Yiyuan International Building, No.319, Xinyi Road, Zhengzhou, Henan Pilot Free Tr
INQUIRY